| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/22/2000 | CA1340903C Process for stabilizing a plasmid present in a bacterial strain and strain thus obtained |
| 02/17/2000 | WO2000008469A1 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis c virus protease |
| 02/17/2000 | WO2000008444A1 Fluorescent assay for biological systems |
| 02/17/2000 | WO2000008443A1 Multiple frequency fluorescence lifetime imaging |
| 02/17/2000 | WO2000008214A1 Oligonucleotide analogs having modified dimers |
| 02/17/2000 | WO2000008213A1 Oligomers which inhibit expression of collagen genes |
| 02/17/2000 | WO2000008212A1 Gel microdrops in genetic analysis |
| 02/17/2000 | WO2000008211A2 Methods and compositions for modulating 'marginally indiscriminant' hybridizations |
| 02/17/2000 | WO2000008209A2 Nucleic acids encoding human tbc-1 protein and polymorphic markers thereof |
| 02/17/2000 | WO2000008206A1 A novel method of diagnosing, monitoring, staging, imaging and treating lung cancer |
| 02/17/2000 | WO2000008204A2 Process for identification of substances modulating urei dependent mechanisms of helicobacter pylori metabolism |
| 02/17/2000 | WO2000008199A1 Molecular cloning of a 7tm receptor (gpr31a) |
| 02/17/2000 | WO2000008198A1 Polyhydroxyalkanoate production from polyols |
| 02/17/2000 | WO2000008196A2 Urate oxidase |
| 02/17/2000 | WO2000008195A1 Method and device for the transfer of oligonucleotides in cells |
| 02/17/2000 | WO2000008194A2 Cell lines for the propagation of mutated herpes viruses |
| 02/17/2000 | WO2000008193A2 Latency-active regulatory sequences of herpesviruses and latency-inactive herpesvirus for gene transfer |
| 02/17/2000 | WO2000008192A2 Herpesviral vectors for gene delivery |
| 02/17/2000 | WO2000008191A2 Herpes virus vectors for dendritic cells |
| 02/17/2000 | WO2000008190A2 Sterol methyltransferase gene |
| 02/17/2000 | WO2000008189A2 Plant resistance gene |
| 02/17/2000 | WO2000008188A1 Transformed plant cell with at least the coding part of the gene coding for fibrillin |
| 02/17/2000 | WO2000008187A2 Genes involved in tolerance to environmental stress |
| 02/17/2000 | WO2000008186A1 New salicylic acid inducible genes and promoters from tobacco |
| 02/17/2000 | WO2000008185A1 Nucleic acid molecule coding for beta-amylase, plants synthesizing a modified starch, method of production and applications |
| 02/17/2000 | WO2000008184A1 Plants which synthesize a modified starch, methods for producing the plants, their use, and the modified starch |
| 02/17/2000 | WO2000008183A1 Mutant e.coli strains, and their use for producing recombinant polypeptides |
| 02/17/2000 | WO2000008182A1 Herpesvirus preparations and their uses |
| 02/17/2000 | WO2000008181A2 Chp polypeptide, a ligand of pak65 |
| 02/17/2000 | WO2000008180A2 HUMAN cDNAs ENCODING POLYPEPTIDES HAVING KINASE FUNCTIONS |
| 02/17/2000 | WO2000008179A1 Ikr-1 and ikr-2, protein kinases which are related to the i kappa b kinases |
| 02/17/2000 | WO2000008178A2 Murine dna molecules encoding polypeptides having kinase functions |
| 02/17/2000 | WO2000008177A2 Death associated kinase containing ankyrin repeats (dakar) |
| 02/17/2000 | WO2000008176A1 Mutated barnase gene and plant transformed by the same |
| 02/17/2000 | WO2000008175A2 Nucleic acid module coding for alpha glucosidase, plants that synthesize modified starch, methods for the production and use of said plants, and modified starch |
| 02/17/2000 | WO2000008174A1 β-CASEIN EXPRESSING CONSTRUCTS |
| 02/17/2000 | WO2000008173A1 Identification and functional characterization of a novel ribosomal s6 protein kinase |
| 02/17/2000 | WO2000008172A1 Method to alter the fatty acid metabolism in plants |
| 02/17/2000 | WO2000008171A1 N-acetylglycosaminyl transferase genes |
| 02/17/2000 | WO2000008170A1 Gene participating in the production of homo-glutamic acid and utilization thereof |
| 02/17/2000 | WO2000008169A1 Dna sequence coding for a 1-deoxy-d-xylulose-5-phosphate synthase and the overproduction thereof in plants |
| 02/17/2000 | WO2000008168A1 Improvements to strains of streptomyces through the use of biosynthetic genes of tylosine |
| 02/17/2000 | WO2000008167A1 Trimer of hiv env gene expression product |
| 02/17/2000 | WO2000008166A1 Recombinant poliovirus for the treatment of cancer |
| 02/17/2000 | WO2000008165A1 Attenuated equine herpesvirus |
| 02/17/2000 | WO2000008164A2 Thermostable in vitro complex with polymerase activity |
| 02/17/2000 | WO2000008163A2 Aromatic amino acid decarboxylase proteins of a parasitic helminth, nucleic acid molecules coding them, and uses thereof |
| 02/17/2000 | WO2000008162A1 A Pi-ta GENE CONFERRING DISEASE RESISTANCE TO PLANTS |
| 02/17/2000 | WO2000008161A1 Transgenic plants with the expression of soybean glycinin |
| 02/17/2000 | WO2000008160A2 A plant disease resistance signalling gene: materials and methods relating thereto |
| 02/17/2000 | WO2000008159A2 Production and use of modified cystatins |
| 02/17/2000 | WO2000008158A2 Molecules designated ldcam |
| 02/17/2000 | WO2000008157A2 Human anion transporter genes atnov |
| 02/17/2000 | WO2000008156A2 Dna replication- and repair-associated proteins |
| 02/17/2000 | WO2000008155A2 Human receptor-associated proteins |
| 02/17/2000 | WO2000008154A1 Pancreatic and ovarian polypeptide, zsig58 |
| 02/17/2000 | WO2000008153A2 Arf-p19, a novel regulator of the mammalian cell cycle |
| 02/17/2000 | WO2000008152A1 Novel orphan cytokine receptors |
| 02/17/2000 | WO2000008151A1 Calcium/calmodulin dependent kinase and an alternative splice product thereof |
| 02/17/2000 | WO2000008150A1 Method for treatment of invasive cells |
| 02/17/2000 | WO2000008149A2 Human neuronal acid-sensitive cationic channels, its cloning and applications |
| 02/17/2000 | WO2000008148A1 Nucleic sequences coding for an at2 interacting protein interacting with the at2 receptor and their applications |
| 02/17/2000 | WO2000008147A1 Genes involved in the molecular paths for tumour suppression and /or resistance to viruses |
| 02/17/2000 | WO2000008146A2 Novel tension-dependent potassium channel and the use thereof in the development of new therapeutic agents |
| 02/17/2000 | WO2000008145A2 Novel genes in control of hematopoiesis |
| 02/17/2000 | WO2000008144A1 Dna encoding a human inhibitor-of-apoptosis protein; hiap3 |
| 02/17/2000 | WO2000008143A2 Gene isolated on the short arm of human chromosome 17 |
| 02/17/2000 | WO2000008142A2 Fibrous proteins and the production thereof |
| 02/17/2000 | WO2000008141A2 Short oligonucleotides for the inhibition of vegf expression |
| 02/17/2000 | WO2000008140A2 Antisense oligonucleotides for the inhibition of vegf expression |
| 02/17/2000 | WO2000008139A1 Tumor necrosis factor-gamma |
| 02/17/2000 | WO2000008138A2 Ribosomal rna (rrn) operon altered bacteria and uses thereof |
| 02/17/2000 | WO2000008137A2 Transgenic animals having a modified glycoprotein v gene |
| 02/17/2000 | WO2000008133A1 NOVEL G PROTEIN-COUPLED RECEPTOR cDNA SEQUENCE |
| 02/17/2000 | WO2000008131A2 Pseudotyped retroviruses and stable cell lines for their production |
| 02/17/2000 | WO2000008056A1 NOVEL POLYPEPTIDE, cDNA ENCODING THE SAME AND UTILIZATION THEREOF |
| 02/17/2000 | WO2000008055A1 A human vamp-2 like gene (cbcbmh06) |
| 02/17/2000 | WO2000008054A1 Modified green fluorescent protein |
| 02/17/2000 | WO2000008053A1 Novel g-protein coupled receptor protein and dna thereof |
| 02/17/2000 | WO2000008051A2 Immunological herpes simplex virus antigens and methods for use thereof |
| 02/17/2000 | WO2000008045A2 Novel molecules of the tango-93-related protein family and uses thereof |
| 02/17/2000 | WO2000008044A1 2'-o-aminoethyloxyethyl-modified oligonucleotides |
| 02/17/2000 | WO2000008043A2 Prevention and treatment of viral disease |
| 02/17/2000 | WO2000008042A1 Aminooxy-modified nucleosidic compounds and oligomeric compounds prepared therefrom |
| 02/17/2000 | WO2000008041A1 Structural analogs of amine bases and nucleosides |
| 02/17/2000 | WO2000008031A1 Novel phospholipids with unsaturated alkyl and acyl chains |
| 02/17/2000 | WO2000007728A2 Micro-system with multiple points for chemical or biological analysis |
| 02/17/2000 | WO2000007632A1 A novel method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 02/17/2000 | WO2000007631A1 Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response |
| 02/17/2000 | WO2000007629A2 Peg-urate oxidase conjugates and use thereof |
| 02/17/2000 | WO2000007618A2 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof |
| 02/17/2000 | WO2000007614A1 Remedies for nerve degeneration diseases |
| 02/17/2000 | WO2000007609A1 Peptide antagonists of zonulin and methods for use of the same |
| 02/17/2000 | WO2000007545A2 Apoptosis proteins |
| 02/17/2000 | WO2000007438A1 Use of an animal model deficient in p53 and having memory deficiency and/or behavioural disorders for therapeutic purposes |
| 02/17/2000 | WO2000007434A1 Novel genetic materials for transmission into maize |
| 02/17/2000 | WO2000007433A1 Plants, seeds and oils having an elevated total monounsaturated fatty acid content |
| 02/17/2000 | WO2000007432A1 Biodegradable high oxidative stability oils |
| 02/17/2000 | WO2000007431A1 Translation control elements for high-level protein expression in the plastids of higher plants and methods of use thereof |
| 02/17/2000 | WO2000007430A2 Plant fatty acid desaturase promoters |